ReviewMaterials (Basel, Switzerland)2025
Antiviral Surface Coatings: From Pandemic Lessons to Visible-Light-Activated Films.
Review in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing need for effective antiviral strategies has led to the development of innovative surface coatings to combat the transmission of viruses via fomites. The aim of this review is to critically assess the efficacy of antiviral coatings in mitigating virus transmission, particularly those activated by visible light. The alarm created by the COVID-19 pandemic, including the initial uncertainty about the mechanisms of its spread, attracted attention to fomites as a possible source of virus transmission. However, later research has shown that surface-dependent infection mechanisms need to be carefully evaluated experimentally. By briefly analyzing virus-surface interactions and their implications, this review highlights the importance of shifting to innovative solutions. In particular, visible-light-activated antiviral coatings that use reactive oxygen species such as singlet oxygen to disrupt viral components have emerged as promising options. These coatings can allow for obtaining safe, continuous, and long-term active biocidal surfaces suitable for various applications, including healthcare environments and public spaces. This review indicates that while the significance of fomite transmission is context-dependent, advances in material science provide actionable pathways for designing multifunctional, visible-light-activated antiviral coatings. These innovations align with the lessons learned from the COVID-19 pandemic and pave the way for sustainable, broad-spectrum antiviral solutions capable of addressing future public health challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.